Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
2(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
6%
Ph not_applicable
1
6%
Ph phase_1
14
88%

Phase Distribution

14

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
14(87.5%)
Phase 2Efficacy & side effects
1(6.3%)
N/ANon-phased studies
1(6.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

2

trials recruiting

Total Trials

16

all time

Status Distribution
Active(6)
Completed(8)
Terminated(1)
Other(1)

Detailed Status

Completed8
Not yet recruiting4
Withdrawn1
Recruiting1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 114 (87.5%)
Phase 21 (6.3%)
N/A1 (6.3%)

Trials by Status

withdrawn16%
completed850%
not_yet_recruiting425%
recruiting16%
unknown16%
active_not_recruiting16%

Recent Activity

2 active trials
Showing 5 of 16
completedphase_1

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults

NCT07655960
recruitingphase_1

Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fasting Conditions

NCT07643220
not_yet_recruitingphase_1

Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fed Conditions

NCT07643233
not_yet_recruitingphase_1

Bioequivalence Study of AJU-C715 and C715R in Healthy Adult Volunteers

NCT07581028
not_yet_recruitingphase_1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

NCT07044765
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT07655960Phase 1

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults

Completed
NCT07643220Phase 1

Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fasting Conditions

Recruiting
NCT07643233Phase 1

Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fed Conditions

Not Yet Recruiting
NCT07581028Phase 1

Bioequivalence Study of AJU-C715 and C715R in Healthy Adult Volunteers

Not Yet Recruiting
NCT07044765Phase 1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

Not Yet Recruiting
NCT07034781Phase 1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults

Not Yet Recruiting
NCT06931327Phase 1

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults

Completed
NCT06933459Phase 1

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults

Active Not Recruiting
NCT05637060Not Applicable

Bioequivalence Study of Rosuvastatin Tablet

Completed
NCT03821480Phase 1

Diflucan Bioequivalence Study For Transferring The Manufacture

Completed
NCT04322032Phase 1

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389

Unknown
NCT04075643Phase 1

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers

Completed
NCT04083872Phase 1

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)

Completed
NCT00000331Phase 2

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6

Withdrawn
NCT01638598Phase 1

Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers

Completed
NCT01260805Phase 1

A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers.

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16